CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a new malaria vaccine, Pfs230D1+R21, aimed at reducing transmission and clinical malaria rates. By utilizing innovative trial designs, the project seeks to establish safety and efficacy, ultimately contributing to malaria control and elimination efforts in Africa.
This proposal responds to the HORIZON 2024 call “EDCTP3 Joint Undertaking:
Research on existing Malaria vaccines and development of new promising candidates.”The malaria epidemic will not stop without a safe, efficacious, and affordable vaccine that can interrupt transmission.
The first licensed malaria vaccines, RTS,S and R21, will substantially reduce childhood deaths in Africa.
We propose to pursue accelerated approval of Pfs230D1+R21, the first multi-stage malaria vaccine to reduce transmiss…
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Mali, Bamako
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
IFAKARA HEALTH INSTITUTE (IHI)
Tanzania, DAR ES SALAAM
Type: Research institute
Activity type: Research Organisations
SME: No
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom, LONDON
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
INSTITUT DE RECHERCHE CLINIQUE DU BENIN (IRCB)
Benin, COTONOU
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
